相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Transcriptional suppression of AMPKα1 promotes breast cancer metastasis upon oncogene activation
Yong Yi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Induction of AMPK activation by N,N′-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers
Jeremy Johnson et al.
PLOS ONE (2019)
Risk factors for distant metastasis of patients with primary triple-negative breast cancer
Yi Yao et al.
BIOSCIENCE REPORTS (2019)
Distinct functions of AKT isoforms in breast cancer: a comprehensive review
Nico Hinz et al.
CELL COMMUNICATION AND SIGNALING (2019)
Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis
Y. Bareche et al.
ANNALS OF ONCOLOGY (2018)
AMPK-Akt Double-Negative Feedback Loop in Breast Cancer Cells Regulates Their Adaptation to Matrix Deprivation
Manipa Saha et al.
CANCER RESEARCH (2018)
AKT1 distinctively suppresses MyD88-depenedent and TRIF-dependent Toll-like receptor signaling in a kinase activity-independent manner
Kosuke Zenke et al.
CELLULAR SIGNALLING (2018)
AMP-activated protein kinase promotes epithelial-mesenchymal transition in cancer cells through Twist1 upregulation
Meera Saxena et al.
JOURNAL OF CELL SCIENCE (2018)
A-674563, a putative AKT1 inhibitor that also suppresses CDK2 activity, inhibits human NSCLC cell growth more effectively than the pan-AKT inhibitor, MK-2206
Paige M. Chorner et al.
PLOS ONE (2018)
Metabolic Hallmarks of Metastasis Formation
Ilaria Elia et al.
TRENDS IN CELL BIOLOGY (2018)
Genetic Markers in Triple-Negative Breast Cancer
Zuzana Sporikova et al.
CLINICAL BREAST CANCER (2018)
Triple-negative breast cancer: is there a treatment on the horizon?
Hui Yao et al.
ONCOTARGET (2017)
AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance
Daniel Garcia et al.
MOLECULAR CELL (2017)
AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins
Marina Riggio et al.
SCIENTIFIC REPORTS (2017)
The PI3K Pathway in Human Disease
David A. Fruman et al.
CELL (2017)
Akt as a target for cancer therapy: more is not always better (lessons from studies in mice)
Qi Wang et al.
BRITISH JOURNAL OF CANCER (2017)
Metabolic changes associated with tumor metastasis, part 2: Mitochondria, lipid and amino acid metabolism
Paolo E. Porporato et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Metabolism in cancer metastasis
Georg F. Weber
INTERNATIONAL JOURNAL OF CANCER (2016)
AMP-activated protein kinase: a cellular energy sensor that comes in 12 flavours
Fiona A. Ross et al.
FEBS JOURNAL (2016)
mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK
Peng Liu et al.
ONCOTARGET (2016)
Triple-negative breast cancer: treatment challenges and solutions
Joelle Collignon et al.
BREAST CANCER-TARGETS AND THERAPY (2016)
The AMP-activated protein kinase (AMPK) and cancer: Many faces of a metabolic regulator
Brandon Faubert et al.
CANCER LETTERS (2015)
Therapies for triple negative breast cancer
Eleni Andreopoulou et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Cancer Stem Cell-Like Phenotype and Survival Are Coordinately Regulated by Akt/FoxO/Bim Pathway
Ricardo Gargini et al.
STEM CELLS (2015)
Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092
Yi Yu et al.
PLOS ONE (2015)
Surviving at a Distance: Organ-Specific Metastasis
Anna C. Obenauf et al.
TRENDS IN CANCER (2015)
PI3K/AKT signaling pathway and cancer: an updated review
Miriam Martini et al.
ANNALS OF MEDICINE (2014)
5′-AMP-activated Protein Kinase (AMPK) Supports the Growth of Aggressive Experimental Human Breast Cancer Tumors
Keith R. Laderoute et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Classes of phosphoinositide 3-kinases at a glance
Steve Jean et al.
JOURNAL OF CELL SCIENCE (2014)
AMP-activated protein kinase: a key regulator of energy balance with many roles in human disease
D. Grahame Hardie
JOURNAL OF INTERNAL MEDICINE (2014)
A kinase-independent function of AKT promotes cancer cell survival
Igor Vivanco et al.
ELIFE (2014)
The AKT Genes and Their Roles in Various Disorders
M. Michael Cohen
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2013)
Akt1 is the principal Akt isoform regulating apoptosis in limiting cytokine concentrations
B. D. Green et al.
CELL DEATH AND DIFFERENTIATION (2013)
AMP-Activated Protein Kinase: A Target for Drugs both Ancient and Modern
D. Grahame Hardie et al.
CHEMISTRY & BIOLOGY (2012)
Preclinical Pharmacology of AZD5363, an Inhibitor of AKT: Pharmacodynamics, Antitumor Activity, and Correlation of Monotherapy Activity with Genetic Background
Barry R. Davies et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Regulation of ubiquitination-mediated protein degradation by survival kinases in cancer
Hirohito Yamaguchi et al.
FRONTIERS IN ONCOLOGY (2012)
Triple negative breast cancer: unmet medical needs
Sumanta Kumar Pal et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Targeting Energy Metabolic and Oncogenic Signaling Pathways in Triple-negative Breast Cancer by a Novel Adenosine Monophosphate-activated Protein Kinase (AMPK) Activator
Kuen-Haur Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Initial steps of metastasis: Cell invasion and endothelial transmigration
Franziska van Zijl et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2011)
PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality
Elena Lopez-Knowles et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Pattern of metastatic spread in triple-negative breast cancer
Rebecca Dent et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Akt1 and Akt2 Play Distinct Roles in the Initiation and Metastatic Phases of Mammary Tumor Progression
Rachelle L. Dillon et al.
CANCER RESEARCH (2009)
Origins and Mechanisms of miRNAs and siRNAs
Richard W. Carthew et al.
CELL (2009)
Metformin induces unique biological and molecular responses in triple negative breast cancer cells
Bolin Liu et al.
CELL CYCLE (2009)
SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells
David Olmeda et al.
CANCER RESEARCH (2007)
Targeted molecular therapy of the PI3K pathway - Therapeutic significance of PI3K subunit targeting in colorectal carcinoma
Piotr G. Rychahou et al.
ANNALS OF SURGERY (2006)
Activation of Akt-1 (PKB-α) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion
JN Hutchinson et al.
CANCER RESEARCH (2004)
分享论文
